Recombinant factor VIIa to treat severe bleeding in patients with liver disease: Pitfalls and possibilities

被引:3
作者
Lisman, Ton [1 ,2 ]
Porte, Robert J. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Sect Hepatobiliary Surg & Liver Transplantat, Groningen, Netherlands
[2] Univ Groningen, Surg Res Lab, Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands
关键词
ACTIVATED FACTOR-VII; HEMOSTASIS; EFFICACY; SAFETY;
D O I
10.1016/j.jhep.2011.03.032
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:950 / 951
页数:3
相关论文
共 10 条
[1]   Recombinant activated factor VII in liver patients: a retrospective cohort study from Australia and New Zealand [J].
Flower, Oliver ;
Phillips, Louise E. ;
Cameron, Peter ;
Gunn, Kerry ;
Dunkley, Scott ;
Watts, Andrew ;
Rajbhandari, Dorrilyn .
BLOOD COAGULATION & FIBRINOLYSIS, 2010, 21 (03) :207-215
[2]   Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile [J].
Levy, Jerrold H. ;
Fingerhut, Abe ;
Brott, Thomas ;
Langbakke, Irene H. ;
Erhardtsen, Elisabeth ;
Porte, Robert J. .
TRANSFUSION, 2006, 46 (06) :919-933
[3]   Control of Life-Threatening Head and Neck Hemorrhage After Dental Extractions: A Case Report [J].
Lieberman, Benn Larkin ;
Kennedy, Michelle K. ;
Lorenzo, Dorothy R. ;
Reed, Louis J. ;
Adamo, Arthur K. ;
Cardo, Vito A., Jr. ;
Badner, Victor M. .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2010, 68 (09) :2311-2319
[4]   Mechanism of action of recombinant factor VIIa [J].
Lisman, T ;
De Groot, PG .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (06) :1138-1139
[5]   Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences [J].
Lisman, Ton ;
Porte, Robert J. .
BLOOD, 2010, 116 (06) :878-885
[6]   Hemostasis and thrombosis in patients with liver disease: The ups and downs [J].
Lisman, Ton ;
Caldwell, Stephen H. ;
Burroughs, Andrew K. ;
Northup, Patrick G. ;
Senzolo, Marco ;
Stravitz, R. Todd ;
Tripodi, Armando ;
Trotter, James F. ;
Valla, Dominique-Charles ;
Porte, Robert J. .
JOURNAL OF HEPATOLOGY, 2010, 53 (02) :362-371
[7]   The effect of temperature and pH on the activity of factor VIIa: Implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients [J].
Meng, ZH ;
Wolberg, AS ;
Monroe, DM ;
Hoffman, M .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2003, 55 (05) :886-891
[8]   Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease [J].
Planinsic, RM ;
van der Meer, J ;
Testa, G ;
Grande, L ;
Candela, A ;
Porte, RJ ;
Ghobrial, RM ;
Isoniemi, H ;
Schelde, PB ;
Erhardtsen, E ;
Klintmalm, G ;
Emre, S .
LIVER TRANSPLANTATION, 2005, 11 (08) :895-900
[9]   Determinants of futility of administration of recombinant factor VIIa in trauma [J].
Stein, DM ;
Dutton, RP ;
O'Connor, J ;
Alexander, M ;
Scalea, TM .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2005, 59 (03) :609-615
[10]   Recombinant activated factor VII in chronic liver diseases: Should we be afraid of thromboembolic events? [J].
Thabut, Dominique ;
Rudler, Marika ;
Rousseau, Geraldine ;
Poynard, Thierry .
JOURNAL OF HEPATOLOGY, 2011, 55 (02) :483-485